4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-000169
EVP & Chief Medical Officer acquired 80,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip EVP & Chief Medical Officer | 2024-01-02 | Option exercise | +18,833 | $0.86 | $16,102 | 206,833 | D |
| Pang Phillip EVP & Chief Medical Officer | 2024-01-02 | Option exercise | +13,576 | $1.58 | $21,382 | 220,409 | D |
| Pang Phillip EVP & Chief Medical Officer | 2024-01-02 | Option exercise | +47,591 | $1.53 | $72,814 | 268,000 | D |
| Derivatives | |||||||
| Pang Phillip EVP & Chief Medical Officer | 2024-01-02 | Option exercise · Stock Option (Right to Buy) | −18,833 | $0.86 | $16,102 | 0 | D |
| Pang Phillip EVP & Chief Medical Officer | 2024-01-02 | Option exercise · Stock Option (Right to Buy) | −13,576 | $1.58 | $21,382 | 0 | D |
| Pang Phillip EVP & Chief Medical Officer | 2024-01-02 | Option exercise · Stock Option (Right to Buy) | −47,591 | $1.53 | $72,814 | 0 | D |
Loading xslF345X05/wk-form4_1704311270.xml…